| Name | Title | Contact Details |
|---|
Synonym is accelerating the worlds biological future by developing, financing and building commercial-scale biomanufacturing facilities. We provide synthetic biology (synbio) producers – from startups to the Fortune 500 – with flexible production capacity while giving infrastructure investors access to a new, carbon-negative biomanufacturing asset class that we are calling "fermentation farms".
Blue Matter Consulting is a management consulting firm dedicated to the life sciences industry, particularly in pharmaceuticals and biotechnology. Founded in 2012, the company has grown from a single office to a global presence with locations in the United States, Europe, and India. The leadership team, including managing partners Ashwin Dandekar, Emily Hua, and George Schmidt, guides the firms strategic growth. The firm offers a wide range of services to help life sciences companies maximize value. These services include new product planning, launch strategy and management, commercial strategy for existing products, market access strategy, corporate strategy, transaction support, and organizational design. Blue Matter also focuses on specific therapeutic areas such as oncology and rare diseases, providing tailored strategies and solutions. With a diverse client base of over 250 companies, including many top global biopharmaceutical firms, Blue Matter Consulting is recognized for its strategic expertise and personalized service in the life sciences sector.
gm3 is the leading web3-native professional services firm. We are dedicated to being the trusted partner of choice for companies and investors looking to navigate the exciting world of web3. Our mission is to provide expert consulting services that empower our clients to unlock the full potential of this transformative technology. gm3 Ventures connects Founders & Investors. For aspiring entrepreneurs, we offer a comprehensive range of financing services tailored to your specific needs. For investors, we provide access to diversified investment opportunities in the web3 ecosystem. With our rigorous due diligence process and curated network, we ensure quality deal flow. gm3 Research specializes in high-end, commissioned research and whitepaper curation across the web3, decentralized finance and technology spaces. Our commitment to excellence is led by Crypto Punk and Harvard University PhD, Dr. Michael Frisch. Together with our team of field experts, we illuminate the path to informed decision-making in the dynamic landscape of web3. gm3 Advisory provides tailored advice and strategic guidance to unlock the potential of web3 for both traditional companies exploring the space and web3-native companies looking to structure and scale their businesses. gm3 Curation offers luxury concierge services across physical art, digital art and high-end fashion. Our creative agency partnership has curated collections for some of the biggest high-end fashion brands in the world. The name gm3 stems from the ubiquitous gm (good morning) greeting that prevails in the decentralized finance & technology spaces. The number 3 represents the last digit in the term web3, which represents the 3rd major evolution of the internet.
At POCN, we seek to support the careers and clinical practices of NPs and PAs - Advanced Clinicians by partnering with life science companies who recognize their critical role on the front lines of healthcare. We are the largest network of Advanced Clinicians in the U.S. and strive to support and enable success for them at every turn. POCN provides Advanced Clinicians with an opportunity engine to grow their careers, earn valuable financial incentives, and increase their clinical knowledge and practice productivity. Recognizing the vital relationship between NPs, PAs, and the broader healthcare and life sciences industries, POCN specializes in developing peer–validated programs that include engaging live and virtual events, helpful patient education resources, incentivized market research programs, clinical reference and prescribing tools, promoted speaking opportunities, as well as CME and continuous learning modules on a variety of disease states and therapies.